We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$264B
AUM Growth
+$16.6B
Cap. Flow
-$3.28B
Cap. Flow %
-1.24%
Top 10 Hldgs %
18.75%
Holding
3,331
New
118
Increased
1,090
Reduced
1,840
Closed
95

Top Sells

Rank Stock Value
1
CSCO icon
Cisco
CSCO
+$474M
2
CELG
Celgene Corp
CELG
+$421M
3
AVGO icon
Broadcom
AVGO
+$411M
4
NFLX icon
Netflix
NFLX
+$387M
5
AAPL icon
Apple
AAPL
+$372M

Sector Composition

Rank Sector Weight
1 Technology 20.51%
2 Financials 14.64%
3 Healthcare 13.3%
4 Consumer Discretionary 10.29%
5 Communication Services 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABTX
2276
DELISTED
Allegiance Bancshares
ABTX
$2.81M ﹤0.01%
74,656
-15,723
-17% -$554K
FLIC
2277
DELISTED
First of Long Island Corp
FLIC
$2.8M ﹤0.01%
111,747
-70,439
-39% -$1.68M
SD icon
2278
SandRidge Energy
SD
$503M
$2.8M ﹤0.01%
659,565
-76,600
-10% -$320K
LEN.B icon
2279
Lennar Class B
LEN.B
$20.8B
$2.79M ﹤0.01%
65,672
-1,522
-2% -$67.6K
XPRO icon
2280
Expro Ltd
XPRO
$1.91B
$2.79M ﹤0.01%
89,924
+29,206
+48% +$894K
GME icon
2281
GameStop
GME
$8.6B
$2.79M ﹤0.01%
1,833,136
-75,076
-4% -$110K
GOSS icon
2282
Gossamer Bio
GOSS
$87M
$2.79M ﹤0.01%
178,240
+7,547
+4% +$152K
CEVA icon
2283
CEVA Inc
CEVA
$1.08B
$2.78M ﹤0.01%
103,231
+15,412
+18% +$421K
AXGN icon
2284
Axogen
AXGN
$2.5B
$2.77M ﹤0.01%
155,029
-4,986
-3% -$73.7K
DDS icon
2285
Dillards
DDS
$9.56B
$2.77M ﹤0.01%
37,734
-2,345
-6% -$166K
XBI icon
2286
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$2.77M ﹤0.01%
29,143
-15,884
-35% -$1.37M
RM icon
2287
Regional Management Corp
RM
$303M
$2.77M ﹤0.01%
92,258
-38,241
-29% -$1.16M
FFIC
2288
DELISTED
Flushing Financial
FFIC
$2.77M ﹤0.01%
128,226
+12,010
+10% +$256K
CSTE icon
2289
Caesarstone
CSTE
$79.5M
$2.76M ﹤0.01%
183,333
+12,604
+7% +$202K
EQBK icon
2290
Equity Bancshares
EQBK
$1.05B
$2.75M ﹤0.01%
89,144
+7,034
+9% +$201K
MIME
2291
DELISTED
Mimecast Limited
MIME
$2.75M ﹤0.01%
63,399
+3,594
+6% +$149K
ATRI
2292
DELISTED
Atrion Corp
ATRI
$2.75M ﹤0.01%
3,656
-2,333
-39% -$1.76M
BMA icon
2293
Banco Macro
BMA
$5.35B
$2.74M ﹤0.01%
75,500
+6,162
+9% +$166K
ACIC icon
2294
American Coastal Insurance
ACIC
$493M
$2.73M ﹤0.01%
216,831
+17,357
+9% +$221K
AAWW
2295
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
$2.73M ﹤0.01%
99,051
-2,657
-3% -$66.3K
BMRC icon
2296
Bank of Marin Bancorp
BMRC
$459M
$2.73M ﹤0.01%
60,572
+10,268
+20% +$454K
CETV
2297
DELISTED
Central European Media Enterprises Ltd
CETV
$2.73M ﹤0.01%
601,887
-274,689
-31% -$1.24M
TVRD
2298
Tvardi Therapeutics
TVRD
$23.4M
$2.72M ﹤0.01%
4,695
-1,344
-22% -$943K
AMAL icon
2299
Amalgamated Financial
AMAL
$1.49B
$2.71M ﹤0.01%
139,482
+100,464
+257% +$1.85M
ICHR icon
2300
Ichor Holdings
ICHR
$2.56B
$2.71M ﹤0.01%
81,340
-2,438
-3% -$72.7K

Similar funds

Nuveen's Q4 2019 Portfolio in Review

As of Q4 2019, Nuveen held 3,331 positions worth $264B, up 6.7% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Nuveen's Q4 2019 filing shows 118 new, 1,090 increased, 1,840 reduced and 95 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B. The largest sale was Cisco, an estimated $474M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Nuveen's largest Q4 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B.
  • Nuveen added most to Bristol-Myers Squibb in Q4 2019, an estimated $649M increase.
  • Nuveen's biggest Q4 2019 reduction was Cisco, cutting an estimated $474M.
  • Nuveen fully exited Celgene Corp in Q4 2019, selling an estimated $421M.
  • Nuveen's ten largest holdings make up 19% of its $264B portfolio in Q4 2019.
  • Nuveen opened 118 new positions and closed 95 in Q4 2019.
  • Nuveen's portfolio value rose 6.7% quarter-over-quarter to $264B.

Based on Nuveen's 13F filing for Q4 2019, filed 14 Feb 2020.